Peptides and liposomes: From biophysical to immunogenic studies

Current Drug Targets

Volumn 4, Issue 8, 2003, Pages 633-642

  Busquets, Maráia Antònia ^a   Alsina, María Asunción ^a   Haro, Isabel ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b DEPARTMENT OF ENVIRONMENTAL CHEMISTRY   (Spain)

Author keywords

Biophysical techniques; Immunology; Lipid monolayers; Liposomes; Model membranes; Synthetic peptides

Indexed keywords

ANTIGEN; DRUG CARRIER; LIPID; LIPOSOME; SYNTHETIC PEPTIDE; VACCINE; VIRUS PROTEIN; WATER;

AMINO ACID SEQUENCE; ARTIFICIAL MEMBRANE; BIOPHYSICS; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; CIRCULAR DICHROISM; DIPOLE; DRUG DELIVERY SYSTEM; DRUG SAFETY; DRUG STRUCTURE; FLUORESCENCE ANALYSIS; HYDROPHOBICITY; IMMUNOGENICITY; INFRARED SPECTROSCOPY; LIPID BILAYER; LIPID MEMBRANE; LIPID VESICLE; MEMBRANE TRANSPORT; MOLECULAR INTERACTION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LIPID INTERACTION; REVIEW; SURFACE CHARGE; SURFACE PROPERTY; TARGET CELL;

ANIMALS; BIOPHYSICS; HUMANS; LIPOSOMES; MEMBRANES, ARTIFICIAL; PEPTIDES;

EID: 0141988645     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389450033490795     Document Type: Review

References (68)

1. Arnon, R. (1991). Molec. Immunol. 28, 209-215
2. Ishiguro, R.; Matsumoto, M; Takahashi, S. (1996). Biochem. 35, 4976-4983.
3. Samuel, O., Shai, Y. (2001). Biochem. 40, 1340-1349.
4. Ben-Efraim, I.; Kliger, Y.; Hermesh, C.; Shai, Y. (1999) J. Mol. Biol. 285, 609-625.
5. Ghosh, J.K.; Shai, Y. (1999) J. Mol. Biol. 292, 531-546.
6. Hancock, R.E.W. (2001) Lancet Infect. Dis. 1, 156-164.
7. Epand, R.M.; Epand, R.F. (2000) Biopol. 55,358-363.
8. Oku, N.; Asai, T.; Watanabe, K.; Kuromi, K.; Nagatsuka, M.; Kurohane, K., Kikkawa, H.; Ogino, K.; Tanaka, M.; Ishikawa, D., Tsukada, H.; Momose, M., Nakayama, J.; Taki, T. (2002) Oncogene 21, 2662-2669.
9. Sheikh, N.A.; Al-Shamisi, M.; Morrow, J.W. (2000) Curr. Opinion Molec. Ther. 2(1) 37-54.
10. Lemon, S.M.;Robertson, B.H. (1993) Sem. Virol. 4, 285-295.
11. Haro, L; Pintó, R.M.; González-Dankaart, J.F.; Pérez, J.A.; Reig, F.; Bosch, A. (1995) Microbiol. Immunol. 39, 845
12. Bosch, A.; González-Dankaart, J.F.; Haro, I. Gajardo, R. Pérez., J.A.; Pintó, R.M. (1998) J. Medical Virol. 54, 95-102.
13. Partidos, C.D.; Vohra, P., Anagnostopoulou, C.; Jones, D.H.; Farrar, G.H.; Steward, M.W. (1996) Mol. Immunol.33,485-491.
14. Celluzzi, C.M.; Mayordomo, J.I.; Storkus, W.J. Lotze, M.T.; Falo, L.D. (1996) J. Exp. Med. 183, 183-287.
15. Brian, J.P.; Barin, C.; van Regenmortel, M.H.V.; Muller, S. (1992) J. Immunol. Methods 156, 255-265.
16. Drummond, D.C.; Meyer, O.; Hong, K.; Kirpotin, D.B.; Papahdjopoulos, D. (1999) Pharmacol. Rev. 51(4), 691-743.
17. Jaafari, M.R., Foldvari, M. (2001) J. Pharm. Sci. 91, 396-404.
18. Lestini, B.J.; Sagnella, M.S.; Xu, Z.; Shive, M.S.; Ritcher, N.J.; Jayaseharan, J.; Case, A.J.; Kottke-Marchant, K., Anderson, J.M.; Marchant, R. E. (2002) J. Controlled Rel. 78, 235-247.
19. Faulkner, L.; Buchan, G.; Slobbe, L.; Lockhart, E.; Wales, J.; Wilson, M.; Baird, M. (2003) Vaccine 21, 932-939.
20. Ullrich, S.E.; Fidler, I.J.; (1992) J. Leukoc. Biol. 52, 489-494.
21. Vallée, B.S.; Tauc, P.; Brochon, J.C.; Maget-Dana, R.; Lelièvre, D. Metz-Boutigue, M.H.; Bureaud, N.; Schoentgen, F. (2001) FEBS Lett. 268, 5831-5841.
22. Haro, I.; Mestres, C., Reig, F.; Alsina, M.A. (1999) Current Topics in Peptide & Protein Research 3, 111-121.
23. Ortiz, A.; Cajal, Y.; Haro, I.; Reig, F.; Alsina, M.A. (2000) Biopol. 53,455-466
24. Sospedra, P.; Mestres, C.; Haro, I.; Muñoz, M.; Busquets, M.A. (2002) Langmuir 18, 1231-1237
25. Van Regenmortel, M.H.V.; Daney de Marcillac, G. (1988) Immunol. Lett. 17, 95-107.
26. Pérez, J.A.; González-Dankaart, J.F.; Reig, F.; Pintó, R.M.; Bosch, A.; Haro, I. (1995) Biomed. Peptides, Proteins & Nucleis Acids 1, 93-100.
27. Haro, I.; Pérez, J.A., Reig, F.; Mestres, C.; Egea, M.A.; Alsina M.A. (1996) Langmuir 12, 5120-5125.
28. Maget-Dana, R. (1999) Biochim. Biophys. Acta 1462, 109-140.
29. Cajal, Y.; Alsina, M.A., Reig, F.; Rodríguez, L.; Mestres, C.; Haro, I. (1998) J. Col. Int. Sci. 198, 78-86.
30. New, R.R.C. in Liposomes, a practical approach. IRL Press Oxford. England. 1992.
31. Lackowicz, J.R. (1983) in Principles of Fluorescence Spectroscopy, Plenum Press. N.Y.
32. Cajal, Y.; Svendsen, A.; De Bolós, J.; Patkar, S.A.; Alsina, M.A. (2000) Biochimie 82, 1053-1061.
33. Chávez, A.; Busquets, M.A.; Pujol, M.; Alsina, M.A.; Cajal, Y. (1998) Analyst 123, 2251-2256
34. Chávez, A.; Pujol, M.; Alsina, M.A.; Cajal, Y. (2001) Luminescence 16, 135-143.
35. Sospedra, P.; Prat, J.; Hato, I.; Mestres, C.; Busquets, M.A. (2001) J. Luminisc. 16, 103-107.
36. Bailey, A.L.; Monck, M.A.; Cullis, P.R. (1997) Biochim. Biophys. Acta 1324, 232-244.
37. Pérez, J.J.; Sharkey, M.; Centeno, N.B. (1996) J. Biomol. Struct. Dynam. 14, 185-191
38. Marshall, G.R. (1992) Curr. Opin. Struct. Biol. 2, 904-919.
39. Blumenstein, M.; Matsueda, G.R.; Timmons, S. and Hawiger, J. (1992) Biochem. 31, 10692-10698.
40. Zvi, A.; Hiller, R. and Anglister, J. (1992) Biochem. 31, 6972-6979.
41. Wooley, G.A. and Deber, C.M. (1987) Biopol. 26, 109-121.
42. Ono, S.; Lee, S.; Mihara, H.; Aoyagi, H.; Kato, T. and Yamasaki, N. (1990) Biochim. Biophys. Acta 1022, 237-244.
43. Gómara, M.J.; Girona, V.; Ercilla, G.; Reig, F.; Alsina, M.A.; Haro, I. (2001) Biopol. 58, 117-128.
44. Gómara, M.J.; Cantó, J.; Alsina, M.A.; Haro, I.; Pérez, J.J. (2001) Lett. in Peptide Sci. 7, 155-162.
45. Pütz, M.M.; Muller, C.P. (2003) Vaccine 21, 663-666.
46. Wang, C.Y.; Chang, T.Y.; Walfield, A.M.; Ye, J.; Shen,M.; Chen, S.P.; Li, M.C.; Lin, Y.L.; Jong, M.H.; Yang. P.C.; Chyr, N.; Kramer, E.; Brown, F. (2002) Vaccine 20, 2603-2610.
47. Lemon, S.M. (1985) New England Journal of Medicine 313, 1059-1067
48. Koff, R.S. (1998) Lancet 351, 1643-1649.
49. Edelman, R. (1980) Rev. Infectious Diseases 2, 370-383.
50. Arnon, R. (1991) Molec. Immunol. 28, 209-215
51. Isaguliants, M.G.; Koshida, R.; Ruden, U. and Wahren, B. (1996) Biochem. 61 (7), 872-877.
52. Isaguliants, R.; Ruden, U.; Wahren, B. (1996) Biochemistry 61 (7), 878-885.
53. Forssen, E.; Willis, M. (1998) Adv. Drug. Del. Rev. 29, 249-271.
54. Heath, T.D.; Bragman, K.S.; Matthay, K.K.; López-Straubinger, N.G.; Papahadjopoulos, D. (1984) Biochem. Soc. Trans. 12, 340-342.
55. Lee, R.J.; Low, P.S. (1997) J. Liposome. Res. 7, 455-466.
56. Kikuchi, A.; Sugaya, S.; Ueda, H.; Tanaka, K.; Aramaki, Y. Hara, T.; Arima, H.; Tsuchiya, S.; Fuwa, T. (1996) Biochem. Biophys. Res. Commun. 160, 666-671.
57. Torchilin, V.P.; Khaw, B.A.; Smirnow, V.N.; Haber, E. (1979) Biochem. Biophys. Res. Commun. 89, 1114-1119
58. Mastrobattista, E.; Koning, G.A.; Storm, G. (1999) Advanced Drug Delivery Reviews 40, 103-127.
59. Hansen, C.B.; Kao, G.Y.; Moase, E.H.; Zalipsly, S.; Allen, T.M. (1995) Biochim. Biophys. Acta 1239, 133-144.
60. Martin, F.J.; Papahadjopoulos, D. (1982) J. Biol. Chem. 257, 286-288.
61. Boeckler, C.; Frisch, B.; Muller, S.; Schuber, F. (1996) J. Immunol. Methods 191, 1-10.
62. Friede, M.; Muller, S.; Briand, J.P.; Van Regenmortel, M.H.V. Schuber F. (1993) Mol. Immunol. 30, 539.
63. Vea, A.; Gómara, M.J.; Reig, F.; Haro, I. (1998) In Innovation and Perspectives in Solid Phase Synthesis & Combinatorial Libraries, (Epton, R. Ed.), pp. 401-404, Mayflower Sci. Ltd. Kingswinford, U.K.
64. García, M.; Alsina, M.A.; Reig, F.; Haro, I. (2000) Vaccine 18(3-4), 276-283.
65. Lestini, B.J.; Sagnella, M.S.; Xu, Z.; Shive, M.S.; Ritcher, N.J.; Jayaseharan, J.; Case, A.J.; Kottke-Marchant, K.; Anderson, J.M.; Marchant, R.E. (2002) J. Control. Rel. 78, 235-247.
66. Varga, C.M.; Wickham, T.J.; Lauffenburger, D.A. (2000) Biotechol. Bioeng. 70, 593-605.
67. Maruyama, K.; Takahashi, N.; Tagawa, T.; Nagaike, K.; Iwatsuru, M (1997) FEBS Lett. 413, 177-180.
68. Tachibana, R.; Harashima, H.; Shinohara, Y.; Kiwada, H. (2001) Ad. Drug Delivery Rev. 52, 219-226.